Increased Infection-Related Mortality in KIR-Ligand–Mismatched Unrelated Allogeneic Hematopoietic Stem-Cell Transplantation
- 15 October 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 78 (7) , 1081-1085
- https://doi.org/10.1097/01.tp.0000137103.19717.86
Abstract
Recently, attention has been focused on the role of killer cell immunoglobulin-like receptor (KIR)-ligand incompatibility between donor and recipient in allogeneic hematopoietic stem-cell transplantation (ASCT). Although KIR-ligand mismatch is clearly associated with improved survival in haploidentical ASCT for acute myeloid leukemia, its role in unrelated human leukocyte antigen-mismatched ASCT is more controversial. Here we present a retrospective analysis of KIR-ligand–matched (n=167) and mismatched (n=23) unrelated ASCTs for hematologic malignancies performed at a single center. We observed that KIR-ligand mismatch was associated with increased transplantation-related mortality (P=0.02), leading to decreased overall survival (P=0.01). The increased transplantation-related mortality was a consequence of a higher rate of infections (P=0.01), whereas incidence of graft-versus-host disease and leukemic relapse did not differ significantly between the two groups. These results suggest that the presence of donor-derived, alloreactive natural killer cells may interfere with immunity to infection in the early posttransplantation period.Keywords
This publication has 17 references indexed in Scilit:
- Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsBlood, 2003
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Alloreactive killer cells: hindrance and help for haematopoietic transplantsNature Reviews Immunology, 2003
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow TransplantationBlood, 1999
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation GroupBlood, 1994
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986